News | April 20, 2026
Pharma stocks face Q4 reality check amid global headwinds
Analysts expect modest revenue growth but pressure on profitability in the March quarter
Analysts expect modest revenue growth but pressure on profitability in the March quarter
In his new role, Curtis will lead the formulation and execution of the company’s global technical strategy
Bajaj joins Health Prime after a long and progressive tenure at Concentrix
The study was conducted by PwC India in line with ISO 14040 and ISO 14044 protocols
The launch coincides with IBS Awareness Month in April
PMDA is regarded among the most stringent regulatory bodies globally
Narasimhan’s appointment underscores the growing importance of AI in transforming drug discovery
Marking three years of the National Diagnostics Catapult (NDxC), the conclave launched the Impact Report and unveiled environmental surveillance kits
The company said it is supporting the ongoing investigation and reiterated its commitment to patient safety.
Genome editing holds extraordinary promise for treating previously incurable genetic diseases
Subscribe To Our Newsletter & Stay Updated
